Biopolymers such as hyaluronic acid (HA) and chitosan are of great importance for cosmetic and medical applications. However, the potential of these substances has so far only been exploited to a limited extent because the technology for industrial processing was not available. If, for example, one tries to dissolve commercially available hyaluronic acid powder in water, depending on the molecule size mixture used, a highly viscous mass is formed from as little as 1 to 2%, which cannot be further processed industrially. This is also the reason why the hyaluronic acid content in common skin care cosmetic products hardly exceeds 1.5%. SolyPlus has overcome this bottleneck with its disruptive platform technology, which allows such and also other biopolymers to be converted from their powder form into so-called "smart materials" (microparticles, films, gels, hard solids) and then processed like wood or plastic. This opens the door to completely new products. Corresponding patents have already been granted in the USA and Europe as well as in India, and applications have also been filed in a number of economically strong countries. Patent protection guarantees sustainable competitive advantages.